Xencor reported $646.94M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amgen AMGN:US $ 8247M 1087M
Arrowhead Research ARWR:US $ 436.89M 8.66M
AstraZeneca AZN:LN 15676M 1246M
Biogen BIIB:US $ 10751.9M 69.7M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cytokinetics CYTK:US $ 16.49M 51.36M
Epizyme EPZM:US $ 67.63M 55.4M
GlaxoSmithKline GSK:LN 15377M 512M
Johnson & Johnson JNJ:US $ 69580M 3746M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Macrogenics MGNX:US $ 319.04M 31.49M
Novartis NOVN:VX SF 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Xencor XNCR:US $ 646.94M 63.33M